For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
The Weill Cornell Medicine (WCM) SPORE consists of four Projects focused on highly translational areas relevant to the detection and treatment of aggressive prostate cancer (PCa).
Projects 1, 2, and 4 build on first-in-class discoveries made by study co-leaders that are fostered with significant preliminary data. Project 3 builds on highly collaborative interactions with multiple SPORE groups, using state-of-the-art genomics in a Clinical Laboratory Improvement Amendments (CLIA) setting.
PROJECTS: Project 1, Project 2, Project 3, Project 4